ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 253 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $131,966 | -18.4% | 24,214 | +0.4% | 0.00% | – |
| Q2 2023 | $161,784 | -20.5% | 24,111 | +4.6% | 0.00% | -100.0% |
| Q1 2023 | $203,540 | +1.8% | 23,051 | -11.9% | 0.00% | 0.0% |
| Q4 2022 | $199,969 | +15.6% | 26,174 | +7.7% | 0.00% | 0.0% |
| Q3 2022 | $173,000 | -9.9% | 24,310 | +3.0% | 0.00% | 0.0% |
| Q2 2022 | $192,000 | -5.4% | 23,601 | +61.3% | 0.00% | – |
| Q1 2022 | $203,000 | -63.6% | 14,635 | -26.4% | 0.00% | -100.0% |
| Q4 2021 | $558,000 | -45.4% | 19,874 | -33.9% | 0.00% | -66.7% |
| Q3 2021 | $1,022,000 | -0.8% | 30,070 | +19.3% | 0.00% | 0.0% |
| Q2 2021 | $1,030,000 | +32.9% | 25,211 | +30.9% | 0.00% | +50.0% |
| Q1 2021 | $775,000 | -37.9% | 19,256 | -8.8% | 0.00% | -60.0% |
| Q4 2020 | $1,248,000 | +17.3% | 21,107 | -3.5% | 0.01% | 0.0% |
| Q3 2020 | $1,064,000 | +8.5% | 21,883 | +7.9% | 0.01% | 0.0% |
| Q2 2020 | $981,000 | +106.1% | 20,274 | +18.3% | 0.01% | +66.7% |
| Q1 2020 | $476,000 | -40.8% | 17,137 | -36.3% | 0.00% | -25.0% |
| Q4 2019 | $804,000 | – | 26,888 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
| Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
| Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
| Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
| Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
| DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
| ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
| Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
| Triatomic Management LP | 102,889 | $560,745 | 0.39% |